Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: Report of four cases

F. Monetti, S. Casanova, A. Grasso, M. A. Cafferata, A. Ardizzoni, C. E. Neumaier

Research output: Contribution to journalArticle

Abstract

Unidimensional Response Evaluation Criteria in Solid Tumor (RECIST) has been recently proposed in the attempt to simplify the standardized bidimensional World Health Organization (WHO) criteria. The complete accord between these two measurement systems was established in a large comparative study [J. Natl. Cancer Inst. 92(3) (2000) 205] that demonstrated the validity and the good performance of RECIST criteria. We report four cases of inadequacy of RECIST criteria in the evaluation of response to chemotherapy in patients with malignant pleural mesothelioma. These four patients were enrolled in two consecutive multicenter phase II clinical trials investigating the activity of a novel chemotherapy regimen in advanced pleural mesothelioma. They were judged as having an objective response to chemotherapy according to WHO criteria. Reassessed according to both methods, we found that results obtained with RECIST criteria do not correspond to WHO underestimating response to chemotherapy. Our data raise doubts about the applicability of unidimensional RECIST response criteria to mesothelioma and, possibly, to any tumor involving the chest wall.

Original languageEnglish
Pages (from-to)71-74
Number of pages4
JournalLung Cancer
Volume43
Issue number1
DOIs
Publication statusPublished - Jan 2004

Fingerprint

Drug Therapy
Mesothelioma
Phase II Clinical Trials
Thoracic Wall
Neoplasms
Malignant Mesothelioma
Response Evaluation Criteria in Solid Tumors

Keywords

  • Chemotherapy
  • CT
  • Mesothelioma
  • RECIST

ASJC Scopus subject areas

  • Oncology

Cite this

Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma : Report of four cases. / Monetti, F.; Casanova, S.; Grasso, A.; Cafferata, M. A.; Ardizzoni, A.; Neumaier, C. E.

In: Lung Cancer, Vol. 43, No. 1, 01.2004, p. 71-74.

Research output: Contribution to journalArticle

Monetti, F. ; Casanova, S. ; Grasso, A. ; Cafferata, M. A. ; Ardizzoni, A. ; Neumaier, C. E. / Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma : Report of four cases. In: Lung Cancer. 2004 ; Vol. 43, No. 1. pp. 71-74.
@article{8ace40bba2f948489600be24a31e5736,
title = "Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma: Report of four cases",
abstract = "Unidimensional Response Evaluation Criteria in Solid Tumor (RECIST) has been recently proposed in the attempt to simplify the standardized bidimensional World Health Organization (WHO) criteria. The complete accord between these two measurement systems was established in a large comparative study [J. Natl. Cancer Inst. 92(3) (2000) 205] that demonstrated the validity and the good performance of RECIST criteria. We report four cases of inadequacy of RECIST criteria in the evaluation of response to chemotherapy in patients with malignant pleural mesothelioma. These four patients were enrolled in two consecutive multicenter phase II clinical trials investigating the activity of a novel chemotherapy regimen in advanced pleural mesothelioma. They were judged as having an objective response to chemotherapy according to WHO criteria. Reassessed according to both methods, we found that results obtained with RECIST criteria do not correspond to WHO underestimating response to chemotherapy. Our data raise doubts about the applicability of unidimensional RECIST response criteria to mesothelioma and, possibly, to any tumor involving the chest wall.",
keywords = "Chemotherapy, CT, Mesothelioma, RECIST",
author = "F. Monetti and S. Casanova and A. Grasso and Cafferata, {M. A.} and A. Ardizzoni and Neumaier, {C. E.}",
year = "2004",
month = "1",
doi = "10.1016/j.lungcan.2003.07.005",
language = "English",
volume = "43",
pages = "71--74",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Inadequacy of the new Response Evaluation Criteria in Solid Tumors (RECIST) in patients with malignant pleural mesothelioma

T2 - Report of four cases

AU - Monetti, F.

AU - Casanova, S.

AU - Grasso, A.

AU - Cafferata, M. A.

AU - Ardizzoni, A.

AU - Neumaier, C. E.

PY - 2004/1

Y1 - 2004/1

N2 - Unidimensional Response Evaluation Criteria in Solid Tumor (RECIST) has been recently proposed in the attempt to simplify the standardized bidimensional World Health Organization (WHO) criteria. The complete accord between these two measurement systems was established in a large comparative study [J. Natl. Cancer Inst. 92(3) (2000) 205] that demonstrated the validity and the good performance of RECIST criteria. We report four cases of inadequacy of RECIST criteria in the evaluation of response to chemotherapy in patients with malignant pleural mesothelioma. These four patients were enrolled in two consecutive multicenter phase II clinical trials investigating the activity of a novel chemotherapy regimen in advanced pleural mesothelioma. They were judged as having an objective response to chemotherapy according to WHO criteria. Reassessed according to both methods, we found that results obtained with RECIST criteria do not correspond to WHO underestimating response to chemotherapy. Our data raise doubts about the applicability of unidimensional RECIST response criteria to mesothelioma and, possibly, to any tumor involving the chest wall.

AB - Unidimensional Response Evaluation Criteria in Solid Tumor (RECIST) has been recently proposed in the attempt to simplify the standardized bidimensional World Health Organization (WHO) criteria. The complete accord between these two measurement systems was established in a large comparative study [J. Natl. Cancer Inst. 92(3) (2000) 205] that demonstrated the validity and the good performance of RECIST criteria. We report four cases of inadequacy of RECIST criteria in the evaluation of response to chemotherapy in patients with malignant pleural mesothelioma. These four patients were enrolled in two consecutive multicenter phase II clinical trials investigating the activity of a novel chemotherapy regimen in advanced pleural mesothelioma. They were judged as having an objective response to chemotherapy according to WHO criteria. Reassessed according to both methods, we found that results obtained with RECIST criteria do not correspond to WHO underestimating response to chemotherapy. Our data raise doubts about the applicability of unidimensional RECIST response criteria to mesothelioma and, possibly, to any tumor involving the chest wall.

KW - Chemotherapy

KW - CT

KW - Mesothelioma

KW - RECIST

UR - http://www.scopus.com/inward/record.url?scp=0346456852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346456852&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2003.07.005

DO - 10.1016/j.lungcan.2003.07.005

M3 - Article

C2 - 14698539

AN - SCOPUS:0346456852

VL - 43

SP - 71

EP - 74

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 1

ER -